CV Sciences (CVSI) Other Non Operating Income (2014 - 2026)
CV Sciences' (CVSI) quarterly Other Non Operating Income came in at $20000.0 in Q1 2026, down 47.37% year-on-year from $38000.0 in Q1 2025, and down 95.31% quarter-over-quarter from $426000.0 in Q4 2025.
CV Sciences (CVSI) Other Non Operating Income (2014 - 2026) Analysis & Trends
CV Sciences has disclosed Other Non Operating Income across 11 years of filings, most recently posting $20000.0 for Q1 2026.
- Other Non Operating Income for Q1 2026 came in at $20000.0, down 47.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $316000.0 (up 670.73% YoY), and the FY2025 annual result was $38000.0, changed N/A from the prior year.
- Other Non Operating Income came in at $20000.0 for Q1 2026 at CV Sciences, down from $426000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $426000.0 in Q4 2025 to a low of -$630000.0 in Q4 2022.
- The 5-year median for Other Non Operating Income is -$10000.0 (2023), against an average of -$57384.6.
- Peak annual rise in Other Non Operating Income reached 972.73% in 2024, while the deepest fall reached 1050.0% in 2024.
- CV Sciences' Other Non Operating Income stood at -$630000.0 in 2022, then surged by 101.75% to $11000.0 in 2023, then jumped by 972.73% to $118000.0 in 2024, then jumped by 261.02% to $426000.0 in 2025, then plunged by 95.31% to $20000.0 in 2026.
- The last three Other Non Operating Income figures came in at $20000.0 (Q1 2026), $426000.0 (Q4 2025), and -$130000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | CV Sciences | - | - | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,000.00 |
| Dec 31, 2025 | 426,000.00 |
| Jun 30, 2025 | -130,000.00 |
| Mar 31, 2025 | 38,000.00 |
| Dec 31, 2024 | 118,000.00 |
| Sep 30, 2024 | -115,000.00 |
| Dec 31, 2023 | 11,000.00 |
| Sep 30, 2023 | -10,000.00 |
| Jun 30, 2023 | -209,000.00 |
| Mar 31, 2023 | -56,000.00 |
| Dec 31, 2022 | -630,000.00 |
| Sep 30, 2022 | 127,000.00 |
| Jun 30, 2022 | -336,000.00 |
| Sep 30, 2021 | 2.95 Mn |
| Dec 31, 2018 | -153,000.00 |
| Mar 31, 2018 | -48,272.00 |
| Dec 31, 2017 | -147,329.00 |
| Sep 30, 2017 | -108,203.00 |
| Jun 30, 2017 | 27,288.00 |
| Mar 31, 2017 | 210,600.00 |